Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
7
×
seattle blog main
seattle top stories
7
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
novartis
amgen
cancer
clinical trials
gene therapy
medicare
merck
pfizer
spark therapeutics
startups
vc
alnylam pharmaceuticals
What
patients
7
×
bio
drug
roundup
drugs
fda
gene
health
market
medical
moves
therapy
acquisitions
advantages
aims
albert
aren’t
bar
becker
biggest
billions
bourla
brings
cancer
carves
ceo
changes
company
computerized
crispr
developers
diet
digital
doctors
dollars
eaton
eisai
estimated
exercise
expect
Language
unset
unknown
Current search:
patients
×
" national blog main "
×
" seattle top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Seattle’s TransformativeMed Carves Out Niche in Medical Specialties
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More